Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| C4 Therapeutics, Inc. | 306,070 | reported | 14 Feb 2026 | tx 34+878,000−151,499 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Feb 2026 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 7,269 | 1.89 USD | |
| 14 Feb 2026 | EXERCISE | C4 Therapeutics, Inc. | 20,950 | 0.00 USD | |
| 13 Feb 2026 | GRANT_AWARD | C4 Therapeutics, Inc. | 200,000 | 0.00 USD | |
| 13 Feb 2026 | EXERCISE | C4 Therapeutics, Inc. | 5,000 | 0.00 USD | |
| 13 Feb 2026 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 1,735 | 1.89 USD | |
| 14 Feb 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 56,500 | 0.00 USD | |
| 13 Feb 2025 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 1,735 | 3.20 USD | |
| 14 Feb 2025 | SALE | C4 Therapeutics, Inc. | 490 | 3.15 USD | |
| 18 Feb 2025 | SALE | C4 Therapeutics, Inc. | 669 | 3.15 USD | |
| 14 Feb 2025 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 2,368 | 3.18 USD | |
| 14 Feb 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 84,700 | 0.00 USD | deriv |
| 07 Nov 2024 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 1,102 | 6.04 USD | |
| 07 Nov 2024 | EXERCISE | C4 Therapeutics, Inc. | 3,750 | — | |
| 07 Nov 2024 | EXERCISE | C4 Therapeutics, Inc. | 3,750 | 0.00 USD | deriv |
| 16 Sept 2024 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 661 | 6.36 USD | |
| 16 Sept 2024 | EXERCISE | C4 Therapeutics, Inc. | 2,250 | — | |
| 16 Sept 2024 | EXERCISE | C4 Therapeutics, Inc. | 2,250 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 115,000 | 0.00 USD | deriv |
| 07 Mar 2024 | OTHER | C4 Therapeutics, Inc. | 115,000 | 0.00 USD | deriv |
| 14 Feb 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 27,300 | 0.00 USD | |
| 13 Feb 2024 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 1,735 | 6.53 USD | |
| 14 Feb 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 122,800 | 0.00 USD | deriv |
| 18 Sept 2023 | GRANT_AWARD | C4 Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |
| 30 Aug 2023 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 661 | 2.93 USD | |
| 30 Aug 2023 | EXERCISE | C4 Therapeutics, Inc. | 2,250 | — |